Replies to post #1930 on Liberty Health Sciences Inc. (fka LHSIF)

[RigorousGains]

Is that why we down -10% today alone?

[scoreoneortwo]

The tie in articles on GGB are very enlightening.

Comment on "handpicking" mgt. is very telling I believe.

I think likelihood of buy out by GGB is very good.

Their(GGB) marketing is top flight and emphasis on US sales is very wise.

Canadian market is limited where USA will be where money is to be made and GGB is run by proven businessmen with established track records.

Synergy would be great.

If GGB does buy LHSIF out,the value of GGB shares will be well worth the effort as they have top flight maketing set up.

I am very excited about this and I am glad I got out of my Canadian MJ stocks as the USA is going to be where it is at!

Too many supporting federalization of medical MJ for it to be held back.

Best is yet to come imho.

“The strongest argument that can be made for Green Growth brands to purchase Liberty Health, undoubtedly, is that of its investor base. This much is clear to anyone that even remotely follows the sector. The Schottenstein family, one of the richest in America, is the financial backer behind Green Growth, and is responsible for taking the company public – to the point of hand picking members of management from other equities in which they own.
“Coincidentally, the Schottensteins also are responsible for the Ohio based operations of Liberty Health Sciences through that of Schottenstein Aphria LLC, of which there are four separate entities. In each case, Liberty Health owns exactly 50.1% of the equity, with a version of “All J’s xxx LLC” owning 49.9% of the equity.”

“Further, the Canadian market is marginal in size and will likely soon be oversaturated, akin to markets in Oregon and Washington State. Sales projections in this market appear to so far have been overstated sector wide, while pricing of cannabis products is set to decline over the next 2-3 years as more and more massive facilities come online.
Add to this a shareholder base that has minimal desire at best to be acquired by a US operator, and its grounds for forgetting about the potential merger altogether. And truth be told, without Aphria’s US assets, it’s hard to make a bullish case for this acquisition that makes logical sense. Instead, Green Growth Brands would be much better off setting its sights on that of Liberty Health Sciences, and setting foot on its path of becoming a true multi state operator.”